Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: A4HF08
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 8 |
GO:0003723 | RNA binding | 4 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.314 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.314 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.664 |
DOC_CKS1_1 | 69 | 74 | PF01111 | 0.498 |
DOC_CYCLIN_RxL_1 | 118 | 125 | PF00134 | 0.514 |
DOC_MAPK_gen_1 | 142 | 151 | PF00069 | 0.514 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.618 |
DOC_WW_Pin1_4 | 68 | 73 | PF00397 | 0.498 |
LIG_14-3-3_CanoR_1 | 121 | 130 | PF00244 | 0.525 |
LIG_BRCT_BRCA1_1 | 217 | 221 | PF00533 | 0.445 |
LIG_FHA_1 | 202 | 208 | PF00498 | 0.615 |
LIG_FHA_2 | 151 | 157 | PF00498 | 0.546 |
LIG_LIR_Nem_3 | 125 | 130 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 78 | 82 | PF02991 | 0.565 |
LIG_PAM2_1 | 6 | 18 | PF00658 | 0.658 |
LIG_PCNA_yPIPBox_3 | 56 | 70 | PF02747 | 0.513 |
LIG_SH2_CRK | 168 | 172 | PF00017 | 0.514 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.564 |
LIG_SH2_SRC | 77 | 80 | PF00017 | 0.481 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.661 |
LIG_SH3_3 | 200 | 206 | PF00018 | 0.654 |
LIG_SH3_3 | 91 | 97 | PF00018 | 0.523 |
LIG_TRAF2_1 | 153 | 156 | PF00917 | 0.514 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.487 |
MOD_CK1_1 | 201 | 207 | PF00069 | 0.624 |
MOD_CK2_1 | 150 | 156 | PF00069 | 0.514 |
MOD_CK2_1 | 191 | 197 | PF00069 | 0.616 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.348 |
MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.625 |
MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.605 |
MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.755 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.680 |
MOD_GSK3_1 | 156 | 163 | PF00069 | 0.493 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.622 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.699 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.589 |
MOD_LATS_1 | 29 | 35 | PF00433 | 0.680 |
MOD_N-GLC_1 | 140 | 145 | PF02516 | 0.314 |
MOD_N-GLC_1 | 185 | 190 | PF02516 | 0.575 |
MOD_N-GLC_1 | 6 | 11 | PF02516 | 0.647 |
MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.650 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.549 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.603 |
MOD_NEK2_2 | 160 | 165 | PF00069 | 0.514 |
MOD_PIKK_1 | 18 | 24 | PF00454 | 0.647 |
MOD_PIKK_1 | 212 | 218 | PF00454 | 0.668 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.788 |
MOD_PKB_1 | 167 | 175 | PF00069 | 0.514 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.624 |
MOD_ProDKin_1 | 68 | 74 | PF00069 | 0.500 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.548 |
TRG_ENDOCYTIC_2 | 168 | 171 | PF00928 | 0.489 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.629 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I044 | Leptomonas seymouri | 68% | 96% |
A0A3Q8IC83 | Leishmania donovani | 87% | 100% |
A4I287 | Leishmania infantum | 86% | 100% |
E9AYD2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4Q6X2 | Leishmania major | 32% | 100% |
Q4Q941 | Leishmania major | 87% | 99% |